Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Selective gene therapy for proliferative disorders: Sense and antisense

Targeting antisense oligonucleotides to c-Raf kinase slows the proliferation of tumor xenografts in mice (pages 668–675).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ross, R. The pathogenesis of atherosclerosis, a perspective for the 1990's. Nature 362, 801–809 (1993).

    Article  CAS  Google Scholar 

  2. Ludwig, S. & Rapp, U.R. Cascading towards vascular disorder gene therapy. Nature Med. 1, 513–515 (1995).

    Article  CAS  Google Scholar 

  3. Krontiris, TG. Oncongens. New Engl. J. Med. 5, 303–306 (1995).

    Article  Google Scholar 

  4. Kohl, N.E. et al. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 260, 1934–1937 (1993).

    Article  CAS  Google Scholar 

  5. Indolfi, C. et al. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Med. 1, 541–545 (1995).

    Article  CAS  Google Scholar 

  6. Wagner, R.W. The state of the art in antisense research. Nature Med. 1, 1116–1118 (1995).

    Article  CAS  Google Scholar 

  7. Stein, C.A. Does antisense exist? Nature Med. 1, 1119–1121 (1995).

    Article  CAS  Google Scholar 

  8. Monia, B.P. et al. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against c-raf kinase. Nature Med. 2, 668–675 (1996)

    Article  CAS  Google Scholar 

  9. Holt, J.T. et al. A ‘senseless’ immune response to DNAs. Nature Med. 1, 407–408 (1995).

    Article  CAS  Google Scholar 

  10. Yokozaki, H. et al. Unhydrolyzable analogue of adenosise 3′-5′-monophosphate demonstrating growth inhibition and differentiation in human cancer cells. Cancer Res. 52, 2504–2508 (1992).

    CAS  PubMed  Google Scholar 

  11. Grieco, D. et al. Requirement for cAMP-PKA pathway activation by M phase-promoting factor in the transition from mitosis to interphase. Science 271, 1718–1722 (1996).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Indolfi, C., Chiariello, M. & Avvedimento, E. Selective gene therapy for proliferative disorders: Sense and antisense. Nat Med 2, 634–635 (1996). https://doi.org/10.1038/nm0696-634

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0696-634

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing